SCHEMBL1064983

SCHEMBL1064983

COc1ccc(C)cc1S(=O)(=O)Nc1cc(CN2C[C@@H]3CC2CN3)c2occc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.55
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ALPL P05186 2/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
ALDH1A1 P00352 2/20 0.40
TSHR P16473 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
LMNA P02545 4/20 0.39
RECQL P46063 1/20 0.39
THRB P10828 2/20 0.39
GAA P10253 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 3/20 0.38
KAT7 O95251 1/20 0.37
KAT6B Q8WYB5 1/20 0.37
KAT6A Q92794 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1063412 1.00 HTR6 (0.55) HTR6MEN1KMT2AALPLSMN1; SMN2
SCHEMBL1063728 1.00 HTR6 (0.55) HTR6MEN1KMT2AALPLSMN1; SMN2
SCHEMBL1060706 0.86 HTR6 (0.40) HTR6MEN1KMT2AALDH1A1LMNA
SCHEMBL1064112 0.86 HTR6 (0.40) HTR6MEN1KMT2AALDH1A1LMNA
SCHEMBL1064111 0.86 HTR6 (0.40) HTR6MEN1KMT2AALDH1A1LMNA
SCHEMBL1064196 0.86 HTR6 (0.56) HTR6MEN1KMT2AALPLSMN1; SMN2
SCHEMBL1064201 0.86 HTR6 (0.56) HTR6MEN1KMT2AALPLSMN1; SMN2
SCHEMBL1064198 0.86 HTR6 (0.56) HTR6MEN1KMT2AALPLSMN1; SMN2
SCHEMBL1062472 0.85 PTPN2 (0.36) HTR6MEN1KMT2AALDH1A1LMNA
SCHEMBL1064509 0.85 PTPN2 (0.36) HTR6MEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820675-B2 Benzofuran compounds BIOVITRUM AB (SE) 2010-10-26 US claimed
US-20060287291-A1 Compounds PROXIMAGEN NEUROSCIENCE PLC (GB) 2006-12-21 US claimed
US-20110015185-A1 Benzofuran Compounds BIOVITRUM AB (SE) 2011-01-20 US disclosed
US-7820675-B2 Benzofuran compounds BIOVITRUM AB (SE) 2010-10-26 US disclosed
US-20060287291-A1 Compounds PROXIMAGEN NEUROSCIENCE PLC (GB) 2006-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287291-A1 Compounds HTR6, HTR1B, HTR1A HTR6 1/4885MEN1 1194/4885KMT2A 3728/4885
US-20110015185-A1 Benzofuran Compounds HTR6, HTR1F, HTR1A HTR6 1/4885MEN1 2814/4885KMT2A 3354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.